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Cutaneous melanoma b a s  an initiâ l p re feren ce  
f o r  lym phatic sp read . R em arkab ly , melanoma  
p ro g re s s io n  to w a r d  Ib is  m eta s ta s iz in g  p h e n o ­
typ e  is accom pan ied  by intense b lood  vessel
a ng iog en e s is bu t lym -
ph an g iogen esi s , the fo rm a tio n  o f  new lymph  
vessels  in the tu m o r , h a s  never been reported ,  
To investigate bow  p r im a r y  melanoma cells in­
teract with the ex is tin g  lym phatic  m icrovascu - 
I attire , and w h e th er  lym phangiogenesis  o c ­
curs, an im nut nos I aining w a s  d eve lo p ed  that 
differentially  d eco ra te s  b lood  an d  lym ph ves­
se ls  in f r o z e n  tissu e  sec tion s . The den sity  and  
distr ibu tion  o f  both th ese  vesse l typ es  in and  
aro u n d  thin (^ 1 .5  m m ) and  th ick (^ 1 .5  mm) 
p r im a r y  melanoma lesions an d  in norm al and  
uninvolved skin w ere  de term in ed . Alt hough e s ­
p ec ia lly  in th ick m elanom a lesions a significant 
increase  in b lood vesse l  den sity  w a s  o b se rv e d , 
lym phatic  density  rem a in ed  u naltered , sh o w ­
ing that lym phangiogenesis  d id  not occur. M or­
p h o lo g ica l  analysis  ind ica ted , h ow ever, that 
m elanom a p ro g re s s io n  is accom pan ied  by a 
sequence o f  events tha t involves bemangiogen- 
e s is  su pportin g  tu m o r  expan sion , especia lly  in
the ver t ica lg ro iv th  ph ase . Often, s trom at sep ta  
a re  fo r m e d  a rou n d  the blood capillaries in the 
tu m or  n eovas cu la t u re p  ro  tec ting th e m f r o  in in - 
vasion. Lymph vessels  inside the tumor were  
inf requently  observed . However, subepiderm al  
lymph vessels  often seemed to be en trapped  
and p e n e tr a te d  by the expanding tumor mass. 
In th is w a y , hemanglogenesis, as the driving  
f o t  'ce behind tu m or expansion, might indi­
rectly increase  the chance o f  lymphatic inva­
sion in t he absence o f  lymphangiogenesis. This 
m odel exp la ins  the p a ra d o x  that, although  
melanoma m eta s ta s is  seems to require angio- 
genestsi a consisten t relation o f  prognosis  with  
blood  cap illary  density  in p r im a ry  cutaneous 
m elanom a is lacking . (Am J  Pathol 1997, 
150:1951-1957)
It has been firmly established that growth of solid 
tumors is dependent on the development of a tumor 
vascular bed/1 Moreover, the transition to an angio­
genic phenotype is assumed to be associated with 
unfavorable prognosis.1" This notion has led to the 
concept that the intensity of tumor angiogenesis cor­
relates with metastatic incidence;''5 This was con­
firmed in a variety of tumors by the finding that a high 
microvascular density, even in a restricted area of
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the tumor (the so-called hot spot) is a negative prog­
nostic factor,4
In other tumor types such as cutaneous melanoma 
and head-and-neck squamous cell carcinoma, this 
correlation is less straightforward.5”7 Although the 
formation of a neovascular bed in cutaneous mela­
noma has been regarded as a sign of malignant 
progression,8” 11 recent extensive analysis has dem­
onstrated that microvascular density is not corre­
lated with metastatic behavior.6 The reason for this 
lack of correlation Is unclear, but it may be specu­
lated that it is caused by the preference of these 
tumors to spread initially via the lymphatic route. It is 
obvious that this preference may be related to a high 
intrinsic lymphatic density in the tissue where the 
tumor arose. Little is known about the presence, 
architecture, and antigenic phenotype of lymph ves­
sels in most tumor types,12,13 and lymphangiogen­
esis in tumors has not been reported in the litera­
ture.14 Study of the lymphatic vascular bed has been 
hampered by the lack of a specific marker for lym­
phatic endothelium. Most immunohlstochemical 
staining methods that decorate endothelial cells do 
not discriminate between blood and lymph vessels 
or do not stain lymphatic vessels at alf. We devel­
oped a differential immunohistochemical double- 
staining protocol using antibody reactivity for CD31 
(platelet-endothelial cell adhesion molecule-1, PE- 
GAM-1) that is present In all types of microves­
sels,15,10 in combination with the blood vessel endo­
thelial marker PAL-E.17 We demonstrate that this 
staining technique selectively decorates the lymph 
and the blood vessels in frozen sections of normal 
skin and primary cutaneous melanoma and that it 
can be used to determine the densities of both these 
vascular beds in the same section.
Materials and Methods
Patient Material
Normal skin specimens were obtained at autopsy. 
Fresh primary melanoma specimens were collected 
from the operating theater of the Department of Der­
matology, University of Wurzburg, Germany. Sam­
ples of 27 melanomas were analyzed by immunohis- 
tochemistry, and 5 melanomas were examined by 
immunoelectron microscopy (4 superficial spreading 
melanomas and 1 lentigo maligna melanoma). On 
hematoxylin-stained sections, tumor thickness, 
Clark's level of invasion, and the growth phase of 
each lesion were determined. The depth of invasion 
according to Clark ranged from level I to level IV, and 
the vertical tumor thickness according to Breslow
varied between in situ melanoma and 11.0 mm, Mel­
anomas with Clark level I or II of invasion were con­
sidered horizontal growth phase melanomas (HG- 
PMs) when the epidermal component was larger 
than the dermal one and when the dermal compo­
nent was arranged in small nests and confined to the 
papillary dermis. Lesions not fulfilling these criteria 
and lesions with level III or IV of invasion were con­
sidered vertical growth phase melanomas (VGPMs). 
Patients had not undergone systemic or local treat­
ment. Each sample was split into portions that were 
either formalin fixed for conventional histopathologl- 
cal diagnosis, snap-frozen for immunohistochemis- 
try, or processed for immunoelectron microscopy,
Antibodies
For immunohistochemistry and immunoelectron mi­
croscopy, monoclonal antibodies (MAbs) against 
CD31 (PECAM-1, 0.5 /¿g/ml) (British Biotechnology, 
ITK Diagnostics, Uithoorn, The Netherlands) and 
CD34 (BioGenex, Klinipath, Duiven, The Nether­
lands), the endothelial marker MAb PAL-E (undiluted 
supernatant; Sanbio, Uden, The Netherlands) and 
polyclonal antisera (pAb) against von Willebrand 
factor/factor Vlll-related antigen (vWF/FVIIIrA; Cen­
tral Laboratory Blood Transfusion Service, Amster­
dam, The Netherlands) and collagen type IV (Coll-IV; 
Organon Teknika, Turnhout, Belgium) were used,
Differential Staining of Lymph and Blood 
Vessels
Four-micron cryosections were air dried and fixed 
in acetone at room temperature for 10 minutes. For 
the first staining reaction, they were incubated for 
60 minutes at room temperature wilh undiluted 
PAL-E supernatant, After this and all following in­
cubation steps, the sections were rinsed with am­
ple phosphate-buffered saline (PBS). Then, the 
secondary 1:200 diluted biotinylated affinity-puri­
fied anti-mouse IgG (Vectastain, Vector Laborato­
ries, Burlingame, CA) was incubated for 30 min­
utes, followed by a 45-minute incubation with 
alkaline phosphatase-biotin avidin complex (ABC 
mouse IgG kit, Vectastain). The first staining was 
developed for 10 minutes with a mixture of 1 mg/ml 
Fast Blue, 0.2 mg/ml naphthol phosphate, and 
0,24 mg/ml levamisole (Sigma-Aldrich, Bornem, 
Belgium). For the second staining, the anti-CD31 
antibody, diluted 1:2000, was incubated for 60 
minutes, followed by a 30-minute incubation of 
1:100 dilution of horseradish-peroxidase-conju­
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gated rabbit anti-mouse immunoglobulin antibody 
(DAKO immunoglobulins, Copenhagen, Denmark). 
The second staining was developed by a 10- 
minute incubation with 0.4 mg/ml amino-9-ethyl- 
carbazole solution (Aldrich, Steinheim, Germany). 
In control sections, one or both of the primary 
antibodies were omitted. Nuclei were counter- 
stained for 2 minutes at room temperature with 1% 
methyl green (Zymed, San Francisco, CA), and the 
sections were mounted in Kaiser’s glycerol gelatin 
(Merck, Darmstadt, Germany).
Determination of Lymph and Blood Vessel 
Density
The number of lymphatics and blood vessels was 
determined in sections of normal skin (n = 14) and in 
melanoma (n = 27) biopsies by visual examination at 
x100 magnification by two independent observers. 
The combination of the delicate red PECAM-1 stain­
ing signal and the presence of melanin precluded 
the use of automated image analysis techniques. 
Vascular counts included complete cross sections, 
partial cross sections, and small groups of positive 
cells. In the melanoma sections, vascular densities 
could be determined in tumor-free fields in 10 cases 
that are Indicated as uninvolved skin. Melanoma 
sections from areas outside the lesion (n = 3) were 
also included as uninvolved skin. In 10 cases, the 
biopsies contained sufficient areas of both unin­
volved skin and tumor to allow for vascular density 
determination. Tumor vascular densities were deter­
mined in both HGPM (n -  12) and VGPM (n -  12). 
For each determination, at least three nonoverlap­
ping fields were counted: the mean number of fields 
counted per section was 4.9 ± 2.1. For statistical 
analysis, the Prism and Instat software programs 
(GraphPad) were used.
Indirect Immunoelectron Microscopy
The samples for immunoelectron microscopy were 
processed as described previously.m,IH
Results
Differential Staining o f Lymph Vessels
To circumvent the lack of a specific marker for lym­
phatic endothelial cells, a protocol was designed 
based on the reactivity of anti-CD31 antibodies with 
both lymphatic and blood vessel endothelial cells in 
combination with the reactivity of a second antibody
with blood vessel endothelium alone. Three blood 
vessel markers were tested. Staining with MAb 
PAL-E was superior to staining with anti-vWF/FVI 11rA 
pAb, anti-Coll-IV pAb, or antl-CD34 MAb. Anti-vWF 
and, to a lesser extent, anti-Coll-IV also reacted with 
lymphatic endothelium, and both the anti-vWF pAb, 
the anti-Coll-IV pAb, and the anti-CD34 MAb pro­
duced high background staining (not shown). Efforts 
to reduce background by dilution to improve speci­
ficity were unsuccessful. Therefore, all further exper­
iments were carried out by using PAL-E
Staining Patterns in Skin Biopsies
Differential staining of normal skin showed a number of 
blood capillaries that were intensely PAL-E positive 
and a number of CD31 -positive, PAL-E-negative 
(CD31 7PAL-E“ ) vascular structures that, on the basis 
of their architecture and characteristic staining pattern, 
were classified as lymphatic vessels (Figure 1a). This 
staining pattern is caused by high CD31 expression on 
inter-endothelial junctions, as has been described pre­
viously for blood vessel endothelium.19 Recently, a 
similar pattern was shown to occur in lymphatic endo­
thelium by staining marker expression in the context of 
ultrastructural morphology.16 Immunoelectron micro­
scopic examination of sections of melanoma biopsies 
labeled with anti-CD31 also showed the junctional 
staining pattern (Figure 2). Often, lymphatic staining 
was completely restricted to these junctions, yielding 
an extremely delicate pattern. Arteries and arterioles 
were not or only faintly stained by PAL-E, as described 
previously,17 but could be identified by vessel wall 
morphology. In addition to the blood vessel endothe­
lium, PAL-E stained the basal lamina of the epider­
mis.*'^ Lymphatic vessels were ubiquitously present in 
high dermal positions, representing the subepidermal 
lymphatic plexus, or accompanying a blood capillary, 
with a lower overall density than blood vessels. Often, 
the lymphatic lumen was compressed, but also very 
large open lymphatic vessels were observed.
Staining Patterns in Biopsies of Human 
Cutaneous Melanoma Lesions
Differential double staining of sections from primary 
cutaneous melanoma lesions showed the tumor-as­
sociated blood and lymphatic vasculature. Extensive 
blood capillary formation (hemangiogenesis) was 
observed in cases of VGPM and occurred through­
out the tumor mass. Often, the tumor was organized 
in cell nests surrounded by stromal septa containing 
the blood capillaries (Figure 1b). In all biopsies, lym-
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Figure 3. Architecture o f  tin  exp a n d in g  cu m  neons m elanom a fasion. a: D ifferential s ta in ing  with PAl.-ii a n d  anti-CDM. b: Schematic drawing o j 
the expanding lesion sh o trn  in  a. The hatched area txprvsenis the Hi ntor mass. Arrows ind ica te  the directions o f  expansion. The boxed area is shown  
in ¡'igutv Ic; in this area, lym ph vessels arc  trapped, H, epidermis; £ m o n o n u c lea r  in f  (It rate ( dotted); V, blood vessels. Magnification, X 100.
blood capillary density was already significantly in­
creased (P <  0.01) in HGPM compared with unin- 
voived skin. Very high blood capillary densities (P < 
0.001) were observed in VGPM, Indicating a local
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process of active hemangiogenesis in these tumor 
lesions. Mean lymphatic density in normal and unin­
volved skin was considerably lower than the mean 
blood vessel density (15 versus 80 cross sections 
per field). Lymphatic density in both HGPM and 
VGPM was comparable to that in normal and unin­
volved skin (P > 0.05). Counting of the lymphatic 
and blood capillary density in the same section en­
abled us to calculate the ratio between these densi­
ties for each Individual melanoma specimen. Com­
parison of these ratios showed a linear correlation 
that was comparable between normal skin, unin­
volved skin, and HGPM (Figure 5). In VGPM, this 
correlation was lost, due to the high and variable 
levels of hemangiogenesis,
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Figure 4, hlood(\op) a n d  lymph (bottom) tvssel density in normal shin 
[NS), nninrolred skin ( t?S), horizontal gmtelh phase primary cutaneous 
melanoma i ih d W ). anti tvrtical gmtrth phase primary cutatieotis mel­
anoma ( V(iPM). i'.ach (mint nptvsents the mean vascular datsity in a 
single hftpsy. The dues n p  resent the otvrall mean rascidar density in the 
indicated category. Jet vis t>f significance of'the difference ofhlood tessel 
density computed with that nteasum l in normal skin <Krttskai- Wailis 
nonfuirametric analysis o f variance an d  D unns multiple comfiurisons 
test) tee tv asfollows: uninrnhvd skin, not significant; ifO'JWI, not sign i f  
icaiK; V(/ /*M, 11 <  O.OOI. i.eix‘Is (ifsignificance computed lei/h nniitrolred 
shin weiv as Ji allows: IHilWJ, 1’ <  (KOI; VG'PM, P <  0.001.
Discussion
To study the lymphatic vasculature in cutaneous lym­
phoma, we developed a staining protocol that differ­
entially highlights the blood and lymph vasculature in 
frozen sections. In our hands (results not shown), this 
method was superior to a previously described pro­
tocol based on differential expression of Ulex euro- 
paeus agglutinin I and collagen type IV.13
The question arises whether the CD31 7PAL-E" 
vascular structures are indeed lymph vessels and, If 
so, whether all lymph vessels are identified by this 
staining. The selectivity of the staining strongly de­
pends on the specificity of the PAL-E MAb. In a 
recent immunoelectron microscopic investigation, 
we were able to identify lymphatic vessels by mor­
phological criteria and study the expression of a 
variety of vascular markers.10 No staining of these 
vessels with the marker PAL-E was observed in any 
case, but they were invariably stained with anti-CD31 
antibody, showing the characteristic intense staining
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Figure 5. Jtatios between blood a n d  lymph vessel density o f  normal 
skin ( NS), uninvolved skin ( US), a n d  horizontal ( HOPAI) an d  vertical 
( VCiPAf) growth phase prim ary cutaneous mcltmunm. Each tfoi repre­
sents the ratio between the mean vascular densities in a single biopsy. 
In each panel, the best filling  straight line is drawn an d  I he corre­
sponding values fo r  con via lion ( r )  an d  level o f significance (p) are 
indicated.
of intercellular junctions. On the basts of this study, 
we concluded that the CD3147PAL-E~ vascular 
structures were lymph vessels and that all lymph 
vessels are decorated by the staining. In a few 
cases, a mononuclear infiltrate was stained by the 
anti-CD31 MAb, which may have interfered with the 
identification of lymphatics in these areas.
The reason for the absence of iymphangiogenesis 
in the presence of' extensive hemangiogenesis is 
unclear. Often, the tumor mass was completely de­
void of lymphatic vessels, which then only were 
found in peritumor dermal regions, it may be spec­
ulated that receptors for angiogenic factors are lack­
ing on lymphatic endothelium or that the lack of 
perivascular cells in the lymph vasculature is of cru­
cial importance, but both these options need further 
study. It is hard to imagine that the extremely high 
blood vessel densities that we observed in several 
cases of VGPM are not related to metastatic inci­
dence. However, blood vessels were often sur­
rounded by perivascular cells and extracellular 
matrix, and the melanoma cells were frequently or­
ganized in tumor nodules separated by a second 
basal lamina from stromal components. This does 
not explain a preference for lymphatic spread com­
pletely, but the morphological findings suggested 
that lymphatic invasion occurred when part of the 
relatively dense subepidermal lymphatic plexus was
trapped between the expanding tumor mass and the 
epidermis and was invaded by the ascending mela­
noma front. Lymphatic vessels in the subtumor re­
gion were not trapped but were pushed away by the 
expanding tumor mass. This model for lymphogenic 
spread provides an explanation for the paradox that 
melanoma progression requires hemangiogenesis 
but that prognosis is not related to the blood capillary 
density.6 It also suggests that lymphatic invasion 
occurs in a particular area, the subepidermal plexus. 
The local architecture of the tissue around the tumor 
and the intrinsic density of the lymphatic bed thus 
may influence prognosis considerably and in this 
way obscure a possible relation with blood capillary 
density. In addition, as lymphatic invasion occurs at 
the interphase of tumor and normal tissue, the rela­
tion between hemangiogenesis and prognosis may 
be lost in the more advanced melanoma lesions 
where the volume of the interphase has become 
relatively small compared with the tumor mass. Re­
cently, blood vessel density was described as a 
prognostic parameter in stage I cutaneous mela­
noma lesions11 in contrast to earlier work where such 
a relation was not found in a larger series including 
more advanced lesions.6
In other tumor types such as breast carcinoma a 
similar scenario as in melanoma could be operative 
as well, Although a relation between capillary density 
and prognosis was established in this tumor type, it 
cannot be ignored that lymph node metastasis is a 
frequent complication and an important independent 
negative parameter of prognosis. We hypothesize 
that here the relation between capillary density and 
lymphatic invasion is a directly proportional one be­
cause it is not influenced by architectural conditions 
such as the presence of a unidirectional barrier like 
the epidermal layer that limits expansion in all dimen­
sions, Further investigation of breast carcinoma and 
other tumor types that preferentially spread initially 
via the lymphatic route is required to confirm this 
proposed model.
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